{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:14:34Z","timestamp":1787764474729,"version":"build-2784847793"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Vision loss is a feared complication in giant cell arteritis (GCA). However, imaging data characterizing intraorbital inflammation and its potential predictive value for ischemic ocular complications remain limited. Such information might be helpful in clinical phenotyping and risk stratification of patients with GCA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This is a retrospective cohort study of patients with GCA, who received at least two [\n                      <jats:sup>18<\/jats:sup>\n                      F]-FDG-PET\/CTs. Quantitative assessment included measurement of SUV\n                      <jats:sub>max<\/jats:sub>\n                      , SUV\n                      <jats:sub>mean<\/jats:sub>\n                      , and the target-to-background ratio (TBR) of both optic nerves (ONs) in the canalicular segment, serving as a surrogate for [\n                      <jats:sup>18<\/jats:sup>\n                      F]-FDG uptake.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 18 patients were included; only 1 had visual symptoms. [\n                      <jats:sup>18<\/jats:sup>\n                      F]-FDG uptake of the ONs was higher in active GCA than in a control cohort [i.e., patients with a primary diagnosis of bronchial carcinoma; median TBR 8.0 (interquartile range 5.2\u201310.0) vs. 1.8 (1.6\u20132.5), respectively;\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.0001]. Under immunosuppressive therapy, the [\n                      <jats:sup>18<\/jats:sup>\n                      F]-FDG uptake of the ONs declined [median TBR of inactive GCA was 5.5 (4.3\u20137.2),\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0009 vs. active GCA]. A TBR of 7.5 distinguishes between active and inactive GCA with a sensitivity of 86.7% and a specificity of 61.1% [area under the curve (AUC) 0.743, 95% confidence interval (CI) 0.574\u20130.912,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0179].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      An unexpected high uptake of [\n                      <jats:sup>18<\/jats:sup>\n                      F]-FDG, corresponding to inflammation of the ONs, could be detected in patients with GCA, most of whom exhibited no visual symptoms. Under immunosuppressive therapy, [\n                      <jats:sup>18<\/jats:sup>\n                      F]-FDG uptake declined, indicating treatment response. These findings suggest that subclinical ON inflammation in GCA may be more prevalent than previously recognized.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1802935","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:59:18Z","timestamp":1773817158000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["[18F]-FDG-PET\/CT detects subclinical optic nerve inflammation in giant cell arteritis"],"prefix":"10.3389","volume":"17","author":[{"given":"Michael","family":"Gernert","sequence":"first","affiliation":[{"name":"Department of Medicine II, Rheumatology and Clinical Immunology, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schmalzing","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Rheumatology and Clinical Immunology, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Fr\u00f6hlich","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Rheumatology and Clinical Immunology, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjun","family":"Zhi","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick-Pascal","family":"Strunz","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Rheumatology and Clinical Immunology, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Labinsky","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Rheumatology and Clinical Immunology, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp E.","family":"Hartrampf","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas K.","family":"Buck","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten A.","family":"Bley","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstanze V.","family":"Guggenberger","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Neuroradiology, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"Werner","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, LMU University Hospital, Ludwig-Maximilians-Universit\u00e4t (LMU) Munich","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian E.","family":"Serfling","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital W\u00fcrzburg","place":["W\u00fcrzburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/xc46ld","article-title":"Revisiting the epidemiology of giant cell arteritis","volume":"43","author":"Gonz\u00e1lez-Gay","year":"2025","journal-title":"Clin Exp Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu329","article-title":"Large-vessel giant cell arteritis: a cohort study","volume":"54","author":"Muratore","year":"2015","journal-title":"Rheumatol (Oxford)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01436-9","article-title":"Large-vessel vasculitis","volume":"406","author":"Cacoub","year":"2025","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"106372","DOI":"10.1016\/j.ejim.2025.06.001","article-title":"Identification of risk factors for permanent visual loss in patients with giant cell arteritis","volume":"139","author":"Solans-Laqu\u00e9","year":"2025","journal-title":"Eur J Intern Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151135","article-title":"Risk factors for permanent visual loss in biopsy-proven giant cell arteritis: A study of 339 patients","volume":"43","author":"Liozon","year":"2016","journal-title":"J Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/01658107.2024.2389934","article-title":"Predictors of permanent vision loss in giant cell arteritis","volume":"49","author":"Tucker","year":"2024","journal-title":"Neuroophthalmology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224543","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update","volume":"83","author":"Dejaco","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-09770-2=","article-title":"Orbital magnetic resonance imaging of giant cell arteritis with ocular manifestations: a systematic review and individual participant data meta-analysis","volume":"33","author":"Guggenberger","year":"2023","journal-title":"Eur Radiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"keaf456","DOI":"10.1093\/rheumatology\/keaf456","article-title":"Transorbital ultrasonography reveals persistent decrease in retinal artery flow and optic nerve diameter in treated giant cell arteritis","author":"Petzinna","year":"2025","journal-title":"Rheumatol (Oxford)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223480","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.155218","article-title":"American college of radiology and society of nuclear medicine and molecular imaging joint credentialing statement for PET\/MR imaging: brain","volume":"56","author":"Jadvar","year":"2015","journal-title":"J Nucl Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/art.21699","article-title":"Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients","volume":"55","author":"Blockmans","year":"2006","journal-title":"Arthritis Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-018-4106-0","article-title":"Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET\/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study","volume":"46","author":"Nielsen","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac125","article-title":"The role of PET\/CT in disease activity assessment in patients with large vessel vasculitis","volume":"61","author":"Galli","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/ard.48.8.667","article-title":"Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica\/giant cell arteritis on presentation and during follow up","volume":"48","author":"Kyle","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200104)45:2%3C140::aid-anr166%3E3.0.co;2-2","article-title":"Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study","volume":"45","author":"Salvarani","year":"2001","journal-title":"Arthritis Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-022-09256-7","article-title":"Intraorbital findings in giant cell arteritis on black blood MRI","volume":"33","author":"Guggenberger","year":"2023","journal-title":"Eur Radiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep011","article-title":"Involvement of the ophthalmic artery in giant cell arteritis visualized by 3T MRI","volume":"48","author":"Geiger","year":"2009","journal-title":"Rheumatol (Oxford)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jcjo.2020.04.002","article-title":"Involvement of the intracranial circulation in giant cell arteritis","volume":"55","author":"Donaldson","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103415","article-title":"Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases","volume":"23","author":"Salvarani","year":"2024","journal-title":"Autoimmun Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1802935\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:59:21Z","timestamp":1773817161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1802935\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2026.1802935"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802935","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"article-number":"1802935"}}